HIPK2 and cancer: In conclusion, our data support a model in which, at the end of cell division, HIPK2 controls abscission acting on midbody regulation and MBR removal, this latter at least through autophagy-mediated degradation with clinical implication in cancer and in neurodegenerative diseases.